EFFECT OF COLLAGEN INDUCED ARTHRITIS ON ANTISTREPTOLYSIN TEST IN THE WHITE LABORATORY RAT
Keywords:RA, CIA, ASTО, immune system, rat
Rheumatoid arthritis (RA) is a serious health challenge as a disease with serious health consequences and
the potential to result in permanent disability. Most of the authors state that the reason for the occurrence of the
disease and its persistence is multifactorial, but above all it is a genetic predisposition as a result of the disruption of
the control mechanisms of the immune system. The disease can occur at any age, but it is most common in patients
over sixty years of age who suffer from damage to the joints, resulting in impaired locomotion, reduced work
capacity, unproductive and poor quality of life. Animal models in RA disease research are useful for studying and
evaluating the effect of potential antiarthritic drugs. The study of the disease in animal models provides useful
information about rheumatoid diseases and RA in humans because of the great similarity in their onset and
Our research aimed to see how collagen type-II induced arthritis would cause an effect on the immune system and
inter alia on ASTO in Wistar rats of both sexes, on the thirtieth and sixtieth days of immunization. ASTO is also
used to diagnose RA secondary to streptococcal infections. Wistar rats, healthy seven-week-old male and female
animals, bred according to standard conditions for experimental animals at the laboratory animal farm at PMFSkopje
were used for the research. The experimental animals were divided into four groups; control group of male
animals (n=20), control group of female animals (n=20), experimental group of male animals (n=30), which were
treated with collagen type-II and experimental group of female animals (n=30), which were also treated with
collagen. Analyzes of aliquots were performed on the thirtieth and sixtieth day of the test. We apply the highly
purified collagen type-II according to a defined protocol in the joint of the back right leg. We took blood for analysis
on the thirtieth and sixtieth day after immunization. The ASTO samples were tested on the computerized and
thermostated Mini NEF TM Duinding Fait apparatus. The principle of the method is based on the fact that
pathogenic beta-hemolytic streptococci of group A produce streptolysin O, which stimulate the body to produce
antistreptolysin. A titer greater than 1/200 is a positive value. From the studies that were done on the influence of
collagen induced arthritis type-II on the value of ASTO in both sexes of animals, in both experimental periods, it can
be concluded that they are within the limits of normal values in all groups and in both sexes. All were <59,430
IU/ml. In general, these studies of RA performed in animal models provide a good parallel for the course and
development of RA in the human population.
Anthony, S.F., Dennis, L.K., Dan, L.L., Eugene, B., Stephen, L.H., Jameson, J.L., & Joseph, L. (2008). Harrison's Principles of Internal Medicine, 17th edition, 2083-2092.
Arnett, F.C. (2021). The American Rheumatism Association 1987 Revised Criteria for the Classification of Rheumatoid Arthritis Rheum 31:315.
Banerjee, S., Anderson, G.D., & Luthra, H.S. (1989). Influence of complement C3, C4 and Vβ T-ceel receptor mutations on susceptibility to collagen-induced arthritis in mice. J. Immunol. 142. 2237-2243.
Banham, A.H., Powrie, F.M., & Suri-Payer, E. (2006). FOXP(3) regulatory T cells: Current controversies and future perspectives (Review). European J. Immunol. 36(11): 2832- 2836.
Bendele, A., Chlipala, L., Sennello, R., Frazier, J., & Edwards, C. (2001). Combination benefit of treatment with soluble TNFRI and IL-1ra in rat models of arthritis. Arthritis Rheum. 43:2648-2659.
Bouwman, L.H., Roep, B.O., & Roos, A. (2018). Mannose-binding lectin: Clinical implications for infection, transplantation and autoimmunity. Human Immunology. 67(4-5): 247-256.
Brooks, P.M., & Day, R.O. (1991). Nonsteroidal anti-inflammatory drugs-differences and similarities. New Engl. J. Med. 324:1716-1272.
Cekada, N., Sestan, M., Hosticka, E., Novoselec, M., Batnozic Varga, M., Padjen, I., Frkovic, M., Kifer, D., Anic, B., & Batinic, D. (2018). Predicting organ damage in patients with childhood-onset systemic lupus erythematosus: a retrospective study over the last 25 years // Pediatric Rheumatology. 16 (Suppl 2): 52. Lisabon, Portugal, 2018. str. P135-P135.
Cooke, A., Zaccone, P., Raine, T., Phillips, J.M., & Dunne, D.W. (2018). Infection and autoimmunity: Are we winning the war, only to lose the peace? Trends in parasitology. 20(7): 316-321.
Ebringer, A., & Rashid, T. (2006). Rheumatoid arthritis is an autoimmune disease triggered by Proteus urinary tract infection. Clinical & Devolopment Immunolog.13 (1): 41-48.
Honda, K., & Littman, D.R. (2018). “The microbiota in adaptive immune homeostasis and disease,” Nature, vol. 535, no. 7610, pp. 75–84.
Joosten, L.A.B., Helsen, M.M.A., van de Loo, F.A.J., & van denBerg, W.B. (1994). Amelioration of established type II collagen induced arthritis (CIA) with anti-IL-1. Agents Actions. 41:C174-C176.
Joosten, L.A.B., Helsen, M.M.A., van de Loo, F.A.J., & van den Berg, W.B. (1996). Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. Arthritis Rheum. 39:797-809.
Kim, E.Y., Sudini, K., Singh, A.K., Haque, M., Leaman, D., & Khuder, S. (2018). Ursolic acid facilitates apoptosis in rheumatoid arthritis synovial fibroblasts by inducing SP1-mediated Noxa expression and proteasomal degradation of Mcl-1. Feaeb. J. 32, 6174–6185. doi:10.1096/fj.201800425r.
Kirwan, J.R. (1995). The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council Low-Dose Glucocorticoids Study Group. Nejm; 333: 142-146.
Maeda, Y., & Takeda, K. (2019). “Host-microbiota interactions in rheumatoid arthritis,” Experimental & Molecular Medicine, vol. 51, no. 12, pp. 1–6.
Oldstone, M.B. (2018). Molecular mimicry, microbial infection, and autoimmune disease: evolution of the concept. Current Topics in Microbiology & Immunology, 296:1-17.
Ozen, S., Marks, S.D., Brogan, P., Groot, N., Graeff, N. De., & Avcin, T. (2019). European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis — the SHARE initiative. Rheumatol. 2019;(March):1607–16.
Pullerits, R., Schierbeck, H., Uibo, K., Liivamägi, H., Tarraste, S., & Talvik, T. (2017). High mobility group box protein 1 - A prognostic marker for structural joint damage in 10- year follow up of patients with juvenile idiopathic arthritis. Semin Arthritis Rheum. 2017; 46(4): 444-450.
Terato, K., Hashida, R., Miyamoto, K., Morimoto, T., Kata, Y., Kobayashi, S., Tajima, T., Otake, S., Horni, P., & Nagai, Y. (1982). Histological, immunological and biochemical studies on type II collagen arthritis in rats. Biomed. Res. 3:495-523.
Wang, L.H., Wu, M.H., Chen, P.C., Su, C.M., Xu, G., & Huang C.C. (2017). Prognostic significance of high-mobility group box protein 1 genetic polymorphisms in rheumatoid arthritis disease outcome. Int J Med Sci.14(13):1382–8.
Van Vollenhoven, R.F., Soriano, A., McCarthey, P.E., Schwartz, R.L., Garbrecht, F.C., Thorbecke, G.J., & Siskind, G.W. (1988). The role of immunity to cartilage proteoglycan in adjuvant arthritis. J. Immunol. 141(4):1168-1173.
Verhoeven, F., Totoson, P., Maguin-Gaté, K., Prigent-Tessier, A., & Marie, C., Wendling, D., et al. (2017). Glucocorticoids improve endothelial function in rheumatoid arthritis: a study in rats with adjuvant-induced arthritis. Clin Exp Immunol. 2017; 188: 208–18. pmid:28152574.
Vinay, K., Abul, K.A., Nelson, F., & Richard, N.M. (2007). Robbins Basic Pathology, 8th edition, 145-147.
Xu, K., Ren, X., Ju, B., Aihaiti, Y., Cai, Y., & Zhang, Y. (2020). Clinical markers combined with HMGB1 polymorphisms to predict efficacy of conventional DMARDs in rheumatoid arthritis patients. Clin Immunol. 221:108592.
Yang, F., Qian, E., & Zhang, M. (2020). “ishen Tongluo formula ameliorates collagen-induced arthritis in mice by modulation of Th17/Treg balance,” Journal of Ethnopharmacology, vol. 250, p. 112428.